Evidence map›Paper›PMID 26212156›Full record

ReviewAdvanced drug delivery reviews2016

Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening.

Yosuke K Kurokawa, Steven C George

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. High throughput screening system for engineered cardiac tissues.Frontiers in bioengineering and biotechnology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Considerations for anFrontiers in pharmacology · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yosuke K KurokawaDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA. Electronic address: yosuke@wustl.edu.
Steven C GeorgeDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA; Department of Energy, Environment, and Chemical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA. Electronic address: scg@wustl.edu.

Funding

Linking DDR2 expression, the cancer-associated fibroblast, and angiogenesis in the tumor microenvironmentUH3TR000481 · NCATS · WASHINGTON UNIVERSITY · PI GEORGE, STEVEN CARL · 2014 to 2016
$2.8M
NCATS NIH HHS UH3 TR000481NCATS NIH HHS UH3-TR-000481
6 · The paper itself

Abstract

The ability to accurately detect cardiotoxicity has become increasingly important in the development of new drugs. Since the advent of human pluripotent stem cell-derived cardiomyocytes, researchers have explored their use in creating an in vitro drug screening platform. Recently, there has been increasing interest in creating 3D microphysiological models of the heart as a tool to detect cardiotoxic compounds. By recapitulating the complex microenvironment that exists in the native heart, cardiac microphysiological systems have the potential to provide a more accurate pharmacological response compared to current standards in preclinical drug screening. This review aims to provide an overview on the progress made in creating advanced models of the human heart, including the significance and contributions of the various cellular and extracellular components to cardiac function.

Indexed as

Models, CardiovascularMyocytes, CardiacPluripotent Stem CellsAnimalsCell DifferentiationDrug Evaluation, PreclinicalEndothelial CellsFibroblastsHeartHumansMyocardial ContractionParacrine CommunicationTissue Engineering3D tissueCardiotoxicityIn vitro drug screeningStem cell-derived cardiomyocyte

Identifiers

PMID26212156
PMCPMC4869857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.